Tag: Koya Medical

Koya Medical launches Dayspring lower extremity active compression treatments for lymphoedema...

Koya Medical recently announced the US commercial availability of its Dayspring active compression system for the treatment of lymphoedema and venous diseases in lower...

Koya Medical secures US$26 million in Series B funding to advance...

Koya Medical has announced the close of a US$26 million Series B financing. The round was led by 3x5 Partners, along with new investors...

Koya Medical presents positive interim data on Dayspring lymphoedema treatment

Koya Medical recently presented data from the company’s prospective, multicentre, randomised, crossover study comparing Dayspring, the company’s active compression treatment for lymphoedema, to a...

Koya Medical receives FDA clearance for Dayspring Lite

Koya Medical has received US Food and Drug Administration (FDA) 510(k) clearance for its Dayspring Lite treatment for lymphoedema and venous disease. Unlike traditional...

Koya Medical secures first reimbursement codes for Dayspring compression system, announces...

Koya Medical recently announced that its wearable, active compression therapy system for lymphoedema—Dayspring—has been issued new billing codes by the Center of Medicare &...

FDA clears Koya Medical’s Dayspring compression system for lower extremities

Koya Medical announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for its active compression therapy system Dayspring for...